When comparing newly diagnosed patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), AML showed a significant increase in IL-4, IL-2 and IL-3, and a significant decrease in VEGF and VCAM-1 [13]. This evidence concerns the gene IL2 and acute lymphoblastic leukemia.